SuperCom Reports Full Year 2020 Financial Results
USA - English
Cash & Restricted Cash increased to $4 million
News provided by
Share this article
(NASDAQ: SPCB),
a global provider of secured solutions for the e-Government, IoT and Cybersecurity sectors, today reported results for the twelve months ended December 31, 2020.
Twelve-Months Ended December 31, 2020 Financial Highlights (Compared to the Prior Year Period)
Cash and cash equivalents and restricted cash increased to $4.0 million from $1.2 million last year.
Revenue decreased 29% to $11.8 million in 2020, from $16.5 million last year, mainly due to material impact from Covid-19 related government restrictions and limitations.
Gross margin increased to 47.4% in 2020 from 38.5% last year.
Operating expenses in 2020 decreased 36% to $9.3 million from $14.5 million last year.
/PRNewswire/ Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today receipt of a written communication from the Food and Drug.
Share this article
Share this article
WAKEFIELD, Mass., April 30, 2021 /PRNewswire/ Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ( Curaleaf or the Company ), a leading international provider of consumer products in cannabis, celebrates the opening of a new Curaleaf-branded location in South Portland, located at 343 Gorham Road, marking the company s first adult-use location in Maine and bringing the Company s total number of retail locations to 106.
Curaleaf has been operating in Maine since 2014, providing access to locally grown products and best-in-class services to the medical market at its three other branded locations. As the first Curaleaf-branded adult-use store in Maine, the South Portland location will bring Curaleaf s high-quality brands and products, including Select, America s #1 cannabis oil brand, to the rapidly growing adult-use market. An opening day ceremony featuring a ribbon cutting, gift bags, and donuts for customers, and 10% off the first purchase
Impressive Q1 performance across all product segments
Double-digit sales and operating profit growth across all product segments in local currencies.
For the Smokefree product segment, continued momentum for
ZYN
drove strong US performance and in Scandinavia good underlying development was further enhanced by timing effects on shipments and COVID-19 related channel mix effects.
For Cigars, record volumes, sales and operating profit on the back of strong category growth and improved price mix.
No major operational COVID-19 related disruptions and COVID-19 related effects in aggregate are estimated to have elevated the reported financial performance.
In local currencies, sales increased by 23 percent for the first quarter. Reported sales increased by 11 percent to 4,455 MSEK (4,029).
Oncolytics Biotech® Announces Annual General Meeting
News provided by
Share this article
SAN DIEGO, Calif. and CALGARY, AB, April 30, 2021 /PRNewswire/ Oncolytics Biotech
® Inc. (NASDAQ: ONCY) (TSX: ONC), (the
Company ) today announced that its upcoming 2021 Annual General Meeting (the
Meeting ) will be held virtually at 12:00 p.m. Eastern Daylight Time (ET) on Friday, May 7, 2021. In light of limits on larger gatherings and in the best interest of the health and safety of our employees and shareholders, the Meeting will be held as a virtual-only shareholder meeting. After the Meeting and at the conclusion of shareholder voting, the management team will provide a corporate update and Q&A for institutional investors and analysts, along with a discussion of our first quarter 2021 financial results.